The ISMP Medication Safety Self Assessment® for Antithrombotic Therapy is designed to:
- Heighten awareness of distinguishing systems and practices related to the safe use of antithrombotic agents
- Assist your interdisciplinary team with proactively identifying opportunities for reducing patient harm when prescribing, storing, preparing, dispensing, and administering antithrombotic therapy
- Create a baseline of your efforts to evaluate risk and evaluate efforts over time.
The self assessment is divided into eight of ISMP's Key Elements of the Medication Use System™ that significantly influence safe use of antithrombotic agents. Each key element is defined by one or more core characteristics of a safe medication use system. Each core characteristic contains individual self-assessment items to help you evaluate the medication safety strategies in your organization.
Download the Assessment Tool Document
This assessment tool has been made possible through funding from Boehringer-Ingelheim Pharmaceuticals, Inc, CSL Behring, and Pfizer, Inc. ISMP would like to thank these organizations for their continued support of efforts to improve medication safety in hospitals and pharmacies worldwide.
ISMP is not a standard setting organization. As such, the self-assessment items in this document are not purported to represent a minimum standard of practice and should not be considered as such. In fact, some of the self-assessment items represent innovative practices and system enhancements that are not widely implemented in healthcare facilities today. However, their value in reducing errors is grounded in scientific research and/or expert analysis of medication errors and their causes.
The ISMP Medication Safety Self Assessment® for Antithrombotic Therapy and its components are copyrighted by ISMP and may not be used in whole or in part for any other purpose or by any other entity except for self assessment of antithrombotic therapy by hospitals and health systems as part of their ongoing quality improvement activities.
